RE:RE:RE:Next financial report at or before April 29$505,000 in losses attributed to Mikra. Good thing you have 200 orders of Cellf at $88 USD each to recoup that. Q1 will have a full quarter of these expenses which is why those financials will be far worse than these ones :)
40,000 wait list = 200 order. That's the muppet math i'd expect from Lifeless shareholders lol
Mostawesomest wrote: Herp derp...uhhh...so they're supposed to develop Mikra and Cellf without incurring expenses...basher logic 101...keep grasping, it amuses me :-)